About Heartland CCOP/Missouri Baptist Medical Center
"Missouri Baptist Medical Center offers a full continuum of medical and surgical services, including heart, cancer, women and infant’s, breast health, gastrointestinal, orthopedic, stroke, therapy, wound and pain management services. The hospital has a 24-hour adult emergency department and cares for pediatric patients at a separate emergency department in collaboration with St. Louis Children’s Hospital and Washington University physicians."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Heartland CCOP/Missouri Baptist Medical Center
During the past decade, Heartland CCOP/Missouri Baptist Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
2015-08-12
2025-12-31
Active, not recruiting
6,452
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Heartland CCOP/Missouri Baptist Medical Center"
#1 collaborator was "Breast International Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Heartland CCOP/Missouri Baptist Medical Center
According to Clinical.Site data, the most researched conditions in "Heartland CCOP/Missouri Baptist Medical Center" are
"Breast Cancer" (1 trials) and "Non-Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Heartland CCOP/Missouri Baptist Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Heartland CCOP/Missouri Baptist Medical Center
Most popular intervention types in "Heartland CCOP/Missouri Baptist Medical Center" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel" (2 trials), "5-Fluorouracil" (1 trials), "Bevacizumab" (1 trials), "Carboplatin" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Heartland CCOP/Missouri Baptist Medical Center
The vast majority of trials in "Heartland CCOP/Missouri Baptist Medical Center" are
2 trials for "All" genders.
Clinical Trials Status at Heartland CCOP/Missouri Baptist Medical Center
Currently, there are NaN active trials in "Heartland CCOP/Missouri Baptist Medical Center".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Heartland CCOP/Missouri Baptist Medical Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Heartland CCOP/Missouri Baptist Medical Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".